AVNR-that's a good forward event to stay on top of.
The company plans to file its full response with the FDA within the next few weeks and expects an approval decision on the drug by the end of the year.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.